Alex Makhnin

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Long Noncoding Rna

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Noura J Choudhury, W Victoria Lai, Alex Makhnin, Glenn Heller, Juliana Eng, Bob T Li, Isabel R Preeshagul, Fernando C Santini, Michael D Offin, Kenneth Ng, Paul K Paik, Christina Larsen, Michelle S Ginsberg, Yvonne Lau, Xinyuan Zhang, Marina K Baine, Natasha Rekhtman, Charles M Rudin
A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Noura J Choudhury, W Victoria Lai, Alex Makhnin, Glenn Heller, Juliana Eng, Bob T Li, Isabel R Preeshagul, Fernando C Santini, Michael D Offin, Kenneth Ng, Paul K Paik, Christina Larsen, Michelle S Ginsberg, Yvonne Lau, Xinyuan Zhang, Marina K Baine, Natasha Rekhtman, Charles M Rudin
A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Noura J Choudhury, W Victoria Lai, Alex Makhnin, Glenn Heller, Juliana Eng, Bob T Li, Isabel R Preeshagul, Fernando C Santini, Michael D Offin, Kenneth Ng, Paul K Paik, Christina Larsen, Michelle S Ginsberg, Yvonne Lau, Xinyuan Zhang, Marina K Baine, Natasha Rekhtman, Charles M Rudin
A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Arielle Elkrief, Alex Makhnin, Khadeja A Moses, Linda S Ahn, Isabel R Preeshagul, Afsheen N Iqbal, Sara A Hayes, Andrew J Plodkowski, Paul K Paik, Marc Ladanyi, Mark G Kris, Gregory J Riely, Franziska Michor, Helena Alexandra Yu
Brief report: Combination of Osimertinib and Dacomitinib to mitigate primary and acquired resistance in EGFR-mutant lung adenocarcinomas. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Arielle Elkrief, Alex Makhnin, Khadeja A Moses, Linda S Ahn, Isabel R Preeshagul, Afsheen N Iqbal, Sara A Hayes, Andrew J Plodkowski, Paul K Paik, Marc Ladanyi, Mark G Kris, Gregory J Riely, Franziska Michor, Helena Alexandra Yu
Brief report: Combination of Osimertinib and Dacomitinib to mitigate primary and acquired resistance in EGFR-mutant lung adenocarcinomas. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)